Astera Labs (ALAB) Projected to Post Earnings on Tuesday

Astera Labs (NASDAQ:ALABGet Free Report) will likely be announcing its Q1 2025 earnings results after the market closes on Tuesday, May 6th. Analysts expect the company to announce earnings of $0.28 per share and revenue of $151.55 million for the quarter. Astera Labs has set its Q1 2025 guidance at 0.280-0.290 EPS.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings data on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. On average, analysts expect Astera Labs to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Astera Labs Trading Up 0.2 %

ALAB stock opened at $66.24 on Tuesday. The stock has a 50-day moving average price of $65.88 and a two-hundred day moving average price of $91.52. Astera Labs has a 1 year low of $36.22 and a 1 year high of $147.39. The stock has a market cap of $10.74 billion and a PE ratio of -38.29.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ALAB. Craig Hallum lifted their target price on Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a research report on Tuesday, February 11th. Needham & Company LLC restated a “buy” rating and set a $140.00 target price on shares of Astera Labs in a report on Tuesday, February 11th. Morgan Stanley lowered their price target on shares of Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 28th. Stifel Nicolaus decreased their price objective on Astera Labs from $150.00 to $100.00 and set a “buy” rating for the company in a report on Thursday, April 17th. Finally, Barclays raised their price target on Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research note on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $109.25.

View Our Latest Analysis on Astera Labs

Insider Activity at Astera Labs

In other news, General Counsel Philip Mazzara sold 50,000 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $87.46, for a total value of $4,373,000.00. Following the transaction, the general counsel now directly owns 191,209 shares of the company’s stock, valued at $16,723,139.14. This represents a 20.73 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Michael E. Hurlston sold 2,500 shares of Astera Labs stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $92.08, for a total transaction of $230,200.00. Following the sale, the director now directly owns 91,794 shares of the company’s stock, valued at $8,452,391.52. The trade was a 2.65 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 633,990 shares of company stock worth $54,235,012.

About Astera Labs

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Stories

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.